GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $189.52 $221.74 Thursday, 18th Apr 2024 BIIB stock ended at $190.52. This is 0.85% less than the trading day before Wednesday, 17th Apr 2024. During the day the stock fluctuated 1.60% from a day low at $189.52 to a day high of $192.55.
90 days $189.52 $252.17
52 weeks $189.52 $319.76

Historical Biogen Inc. prices

Date Open High Low Close Volume
2024-03-13 $228.76 $229.90 $224.93 $226.56 1 463 762
2024-03-12 $229.34 $229.75 $225.35 $227.36 1 056 419
2024-03-11 $223.30 $230.22 $223.24 $230.07 1 197 857
2024-03-08 $225.45 $228.21 $221.98 $223.24 1 606 385
2024-03-07 $219.92 $219.92 $216.69 $219.36 1 096 315
2024-03-06 $217.47 $219.99 $216.83 $217.56 1 432 507
2024-03-05 $219.65 $221.50 $216.50 $217.23 842 471
2024-03-04 $221.17 $222.92 $219.76 $221.02 1 070 565
2024-03-01 $217.46 $222.00 $215.35 $220.95 1 085 129
2024-02-29 $221.76 $222.88 $216.70 $216.99 1 901 435
2024-02-28 $222.25 $224.12 $221.00 $221.74 888 219
2024-02-27 $223.72 $224.87 $220.35 $223.94 965 802
2024-02-26 $222.52 $224.99 $222.00 $223.71 769 203
2024-02-23 $223.43 $225.80 $221.50 $223.32 900 915
2024-02-22 $221.23 $223.22 $218.80 $222.48 834 041
2024-02-21 $221.49 $223.40 $219.00 $221.11 900 831
2024-02-20 $217.56 $220.12 $215.68 $219.21 1 575 086
2024-02-16 $221.15 $221.75 $217.53 $219.08 1 740 446
2024-02-15 $221.15 $224.98 $220.07 $223.35 1 250 936
2024-02-14 $227.01 $227.99 $220.56 $220.74 2 184 901
2024-02-13 $235.64 $237.00 $225.28 $226.65 3 381 018
2024-02-12 $239.45 $244.94 $239.45 $244.74 947 935
2024-02-09 $239.88 $241.36 $238.90 $240.98 684 165
2024-02-08 $239.89 $240.54 $237.54 $240.30 741 876
2024-02-07 $246.44 $246.44 $240.54 $240.54 755 034
Click to get the best stock tips daily for free!

About Biogen Inc.

Biogen. Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an etanercept biosimilar referencing ENBREL; ADUHELM for the treatment of Alzheimer's disease; IMRALDI, an ad... BIIB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT